Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

NCT02595944

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 884 locations
View Trial Details
Active, not recruiting

A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT05879978

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Hôpital Louis Pradel Bron, France
  • CTR François Baclesse Caen, France
View Trial Details
Active, not recruiting

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

NCT06486428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html Multiple Locations, Alabama, United States
  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html Multiple Locations, Alaska, United States
  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html Multiple Locations, Arizona, United States
  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html Multiple Locations, Arkansas, United States
View all 52 locations
View Trial Details
Active, not recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

NCT06305754

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Kaiser Permanente - Oakland ( Site 0054) Oakland, California, United States
  • Kaiser Permanente - Roseville ( Site 0055) Roseville, California, United States
  • Kaiser Permanente - San Francisco ( Site 0056) San Francisco, California, United States
  • Kaiser Permanente - Santa Clara ( Site 0057) Santa Clara, California, United States
View all 156 locations
View Trial Details
Active, not recruiting

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

NCT06120140

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • City of Hope Duarte, California, United States
  • Providence Fullerton Fullerton, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
View all 93 locations
View Trial Details
Active, not recruiting

A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

NCT05388669

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • City of Hope Duarte Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • City of Hope Long Beach Elm Long Beach, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 187 locations
View Trial Details
Active, not recruiting

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

NCT03896503

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +13 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 33 locations
View Trial Details

Related conditions